VRTX 241227 415.00C (VRTX241227C415000) Stock Options, News & Quotes

English
中文繁體
中文简体

Download

Mobile

moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US OptionsDetailed Quotes

VRTX241227C415000

Watchlist

0.02
0.000.00%

15min DelayClose Dec 27 16:00 ET

0.00High0.00Low

Intraday

5D
Daily

News

Wall Street Today: Market Turns Around, Let's See if it Lasts
Kevin Travers16:07 ET
Live Stock News: Monday Market Falling, 'Too Big to Fail' Earnings to Start Q1 Report Season
Kevin TraversJan 13 10:52 ET
Jefferies Maintains Vertex Pharmaceuticals(VRTX.US) With Buy Rating, Maintains Target Price $550
Moomoo NewsJan 13 08:31 ET · Ratings
Truist Financial Maintains Vertex Pharmaceuticals(VRTX.US) With Buy Rating
Moomoo NewsJan 13 08:31 ET · Ratings
Vertex Pharmaceuticals: Strong Future Potential With Key Drug Launches and Underappreciated Opportunities
TipRanksJan 13 08:05 ET
Stifel Maintains Vertex Pharmaceuticals(VRTX.US) With Hold Rating, Maintains Target Price $494
Moomoo NewsJan 13 07:34 ET · Ratings

Comments

101721316

Dec 29, 2024 04:21

$Vertex Pharmaceuticals (VRTX.US)$ long term play

Lnova

Dec 19, 2024 18:23

$Vertex Pharmaceuticals (VRTX.US)$
nfa

Vertex Stock Plunges 13% Over Pain Drug's Disappointing Study Results

Lnova

Dec 19, 2024 18:19

“SiteOne Therapeutics Announces a $100 Million Series C Financing to Advance Selective Ion Channel Modulators as Non-Opioid Treatments for Pain.
SiteOne’s efforts in non-opioid pain management put it in a unique position relative to Vertex Pharmaceuticals, a major player in the field known for its successful development of cystic fibrosis treatments. Vertex has also been working on non-opioid pain drugs, specifically targeting the NaV1.8 sodium channel, a focal point shared by SiteOne’s lead pro...

SiteOne Therapeutics Announces a $100 Million Series C Financing to Advance Selective Ion Channel Modulators as Non-Opioid Treatments for Pain

Kevin Travers

Nov 15, 2024 15:20

Columns Market Falls to End All-Time High Week | Wall Street Today

In the end, a week that starts with an all-time high for the S&P 500, Dow Jones, and Nasdaq 100, ended with equities lower.
At 4:02 p.m. ET, the three indices closed lower. The $Dow Jones Industrial Average (.DJI.US)$ was off 0.70%, losing 300 points. The $S&P 500 Index (.SPX.US)$ was down 1.32% and the $Nasdaq Composite Index (.IXIC.US)$ was off 2.24%.
MACRO
In macro, core retail sales grew by 0.1% month over month, lower than estimated. ...

Live Stock Financial Podcast. What are you watching on the market?

Kevin Travers

Nov 15, 2024 10:12

Columns Market Falls Friday on Earnings | Live Stock

You will not get through the trading day without the news and animal spirits guiding the market. It is finally Friday, November 15th.
My name is Kevin Travers and the market is falling today- here is why.
$Alibaba (BABA.US)$ shares declined after a report from the firm Friday morning that it was facing a consumer demand slump, even though its AI cloud business grew 7% to $4.2B in its second fiscal quarter.
$Applied Materials (AMAT.US)$ fell 8% after r...

Powell says no hurry for Fed rate cuts, how will you adjust your investment strategy?